(Q44008845)

28 November 2017

Longstanding atrial fibrillation causes depletion of atrial natriuretic peptide in patients with advanced congestive heart failure (English)

1 reference

atrial natriuretic peptide

28 November 2017

0 references

atrial fibrillation

1 reference

based on heuristic

inferred from title

congestive heart failure

1 reference

4

Frans Boomsma

0 references

Dirk J van Veldhuisen

6

object named as

Dirk J van Veldhuisen

1 reference

28 November 2017

Harry J. G. M. Crijns

5

object named as

Harry J G M Crijns

1 reference

28 November 2017

Maarten P van den Berg

1

1 reference

28 November 2017

Geert Tjeerdsma

2

1 reference

28 November 2017

Pieter Jan de Kam

3

1 reference

28 November 2017

Frans Boomsma

4

1 reference

28 November 2017

1 June 2002

1 reference

European Journal of Heart Failure

28 November 2017

1 reference

28 November 2017

4

1 reference

28 November 2017

255-262

1 reference

28 November 2017

3

1 reference

A functional role for endogenous atrial natriuretic peptide in a canine model of early left ventricular dysfunction

28 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900232-X

Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900232-X

Comparison of plasma neurohormones in congestive heart failure patients with atrial fibrillation versus patients with sinus rhythm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900232-X

Disturbed secretion of atrial natriuretic peptide in patients with persistent atrial standstill: Endocrinologic silence

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900232-X

Importance of neuroendocrine activation in chronic heart failure. Impact on treatment strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900232-X

Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900232-X

Pathology of atrial fibrillation in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900232-X

Myocardial cell death in fibrillating and dilated human right atria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900232-X

The role of arrhythmias in the progression of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900232-X

Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD)

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900232-X

Metabolic clearance rate and plasma half life of alpha-human atrial natriuretic peptide in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900232-X

Circulating N-terminal atrial natriuretic peptide as a marker for symptomless left-ventricular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900232-X

Atrial stretch, not pressure, is the principal determinant controlling the acute release of atrial natriuretic factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900232-X

Atrial natriuretic factor during atrial fibrillation and supraventricular tachycardia

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900232-X

Natriuretic peptide levels in atrial fibrillation: a prospective hormonal and Doppler-echocardiographic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900232-X

Atrial natriuretic peptide in patients with heart failure and chronic atrial fibrillation: role of duration of atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900232-X

Randomised study of effect of ibopamine on survival in patients with advanced severe heart failure. Second Prospective Randomised Study of Ibopamine on Mortality and Efficacy (PRIME II) Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900232-X

Influence of age on neurohormonal activation and prognosis in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900232-X

Sequential neurohumoral measurements in patients with congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900232-X

Atrial electrophysiologic remodeling: another vicious circle?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900232-X

The effects of atrial fibrillation on atrial pressure-volume and flow relationships

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900232-X

Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900232-X

The relationship of human atrial cellular electrophysiology to clinical function and ultrastructure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900232-X

High prevalence of atrial fibrosis in patients with dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900232-X

Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900232-X

Regulation of angiotensin II receptor subtypes during atrial fibrillation in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900232-X

Renal disposal of human atrial natriuretic peptide in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900232-X

Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. Studies of Left V

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900232-X

Generalized Linear Models

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900232-X

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S1388-9842(01)00232-X

1 reference

28 November 2017

1 reference